Audit and assurance
Novo Nordisk applies an integrated approach to reporting on the company’s financial and non-financial performance. Hence, the Annual Report follows current international reporting standards in terms of both mandatory and voluntary reporting.
Since the publication of our first Environmental Report in 1994, Novo Nordisk has had external third parties to review the data and information published in external reporting. Novo Nordisk strongly believes that external assurance is an important element of being accountable and transparent in reporting.
The assurance process is not just important to us but also to our stakeholders. It is important that what we report is material, complete and done in a responsive manner to our stakeholders.
The consolidated financial statements of the Annual Report have been presented in accordance with IFRS, and the Annual Report as a whole in accordance with the Danish Financial Statements Act and additional Danish reporting requirements. In addition, the Annual Report is in support of the United Nations Global Compact (GC). The Annual Report has been assured according to AA1000AS. Novo Nordisk has used AA1000AS in its assurance process since 2002. In 2007, we changed Novo Nordisk’s Global Reporting Initiative reporting to be aligned with the GRI G3 Guidelines. Read more about our GRI G3 reporting here.
Our assurance process is aligned with the internal control processes in the company, from individual affiliates and facilities to board level. For Novo Nordisk it is important to understand that different elements assure in different ways for different stakeholders. You can read about how we obtain different types of assurance in 'What assures?'.
The assurance process related to the Annual Report consists of an internal and an external assurance process.
See the full details in the:
The information presented in the ‘Values in action’ section has been assessed by Pricewaterhouse-Coopers. See the Assurance Report on Non-Financial Reporting 2007 for a full description of the nature of assurance offered.
In its assessment, PricewaterhouseCoopers has checked that the reporting (the Annual Report and the supplementary information available in the ‘Values in action’ section) contains the required information and indicators.
The consolidated corporate performance data are part of PricewaterhouseCoopers’ assurance of the Annual Report 2007 with reference to the Assurance Report on Non-Financial Reporting 2007. See the full list of assured consolidated performance data.
This page has been reviewed by PricewaterhouseCoopers as part of its assurance of Novo Nordisk’s non-financial reporting. Please refer to Audit and assurance for a full description of the conclusions and the nature of assurance offered.
